Through several rounds of competition with more than a dozen well-known IVD R&D and manufacturing companies, Konsung was awarded a nearly multi-million dollar project grant based on a dry biochemical technology platform by FIND in September. We have signed a cooperation agreement with FIND to create medical testing systems for global low- and middle-income countries , and jointly improve the level of medical testing devices worldwide.
The Foundation for Innovative New Diagnostics (FIND), a strategic partner of the World Health Organization, is a global non-profit organization that works with more than 200 researchers, institutions, governments, and organizations around the world to advance the development and innovation of diagnostic technologies that support disease surveillance, control, and prevention.
Founded in 2013, Jiangsu Konsung Bio-medical and Science Technology Co., Ltd. is an innovative technology company focusing on in vitro diagnosis, family medicine, mobile medicine, pet medicine and enlarged health ecological chain technology. Konsung is the only one domestic supplier which focusing on a full range of solutions for primary care, and the first Chinese enterprise to enter the United Nations and the World Bank respiratory products procurement catalog. The domestically initiated whole blood microfluidic hemoglobin analyzer has made a major breakthrough in the global market and Konsung is the only Chinese manufacturer to enter this field.
Konsung has been committed to high-tech medical technology and benefit the global primary care. Through many years of research and development accumulation, we have mastered multi-analyte whole blood filtration technology, multi-wavelength time-division multiplexing sensing technology, microfluidic quantification and mass production technology, and it realized the perfect combination of high performance, low cost and primary availability of dry biochemical technology. Wang Qiang, CEO of Konsung, said: ”The cooperation with FIND not only reflects Konsung’s global market expansion ability, but also reflects Konsung’s scientific research strength. It is hoped that we can help low- and middle-income countries to obtain efficient diagnosis and treatment technologies as soon as possible through resource and information sharing in this cooperation.”
Post time: Sep-30-2022